Our Summit Inspires You To:
Our Summit Inspires You To:
Learn from industry leaders who share their organizational journeys on data governance and its impact on data management, AI/ML, and regulatory submissions across the Life Science R&D workflow.
Listen to leading experts and practitioners driving changes and innovations in Life Sciences.
Engage with your peers, leaders, and professionals to achieve your goals.
Listen to leading experts and practitioners driving changes and innovations in Life Sciences.
Engage with your peers, leaders, and professionals to achieve your goals.
Watch On-Demand
Watch On-Demand
ABOUT THE SUMMIT
ABOUT THE SUMMIT
This year's summit aims to provide actionable insights from life science experts on how data governance creates successful AI/ML programs, ensures better outcomes for a collaborative approach to regulatory submissions, and enhances clinical data management. Whether you are a seasoned Egnyte customer or a first-time user, this event offers an excellent opportunity to engage with and inspire other Life Science leaders.
TITLE: | Keynote: The Impact of Technology in Today’s Clinical Trial Ecosystem |
SPEAKERS: |
Ken Getz | Executive Director | Tufts Center for the Study of Drug Development
Bill Fitzgerald | Head of Biotechnology Markets | Americas Google Cloud
Abhay Kini | Director, Life Sciences | Egnyte
|
DESCRIPTION: | Accelerating clinical trial timelines, managing costs, and faster time to patient is the holy grail of clinical research. Listen to Ken Getz, Research Professor, Tufts University School of Medicine, for our opening keynote that explores the state of clinical trials today and the impact of technology solutions on the clinical trial operating environment. |
TITLE: | Session: Ensuring Seamless Collaboration Throughout Drug Discovery |
SPEAKER: | Dr. Rebecca Carazza | Executive Director, Head of Information Systems | Nimbus Therapeutics |
DESCRIPTION: | Collaborating with external partners is crucial in the biopharmaceutical industry and can create challenges in managing data, maintaining security, and complying with regulations. Dr. Rebecca Carazza will share how Nimbus Therapeutics leveraged data governance as a foundation to collaborate with its partners and maintain data integrity in working across its partner network. |
TITLE: | Session: Streamlining Clinical Data Management: Harnessing the Cloud for Biotech Breakthroughs |
SPEAKER: | Jon Weiss | Partner and Chief Innovator | Basis Digital Biotech |
DESCRIPTION: | Robust security, compliance, and governance controls are critical to scaling and simplifying modern clinical data platforms. Watch Jon Weiss about an insightful journey on how Egnyte can provide a cloud-native multilingual platform to enable a cutting-edge approach to statistical analysis of clinical data. |
TITLE: | Session: Underscoring the Importance of Data Governance in Clinical Development Technology |
SPEAKERS: | Mike Lynch | Senior Specialist | Halloran Karen Travers | Principal | Halloran |
DESCRIPTION: | Data governance is vital in the life sciences industry, particularly concerning Electronic Document Management Systems (EDMS), Electronic Trial Master File (eTMF), Clinical Study Reports, and Statistics. Without standardized governance practices, we risk amplifying disorganized and unreliable data. Watch Karen Travers and Mike Lynch, Halloran experts, as they share their experience of how governance frameworks are essential for maintaining data integrity and regulatory compliance across the clinical development lifecycle. |
TITLE: | Panel Discussion: Impact of AI in R&D |
SPEAKERS: | Murtaza Cherawala | Senior Director of Data Management and Artificial Intelligence | Alnylam Pharmaceuticals Jacob Oppenheim | Entrepreneur in Residence | Digitalis Ventures Nate McBride | Senior Vice President, Information Technology | Xilio Cat Hall | Head of GXP Quality Assurance | Egnyte |
DESCRIPTION: | AI is a hot topic in biotech, but how much is real and how much is fantasy? Watch experts from Digitalis Ventures, Alnylam and Xilio as they discuss how AI is changing Clinical Research today and how to prepare for tomorrow. |
TITLE: | Session: Ask the Experts |
SPEAKERS: | Abhay Kini | Director, Life Sciences | Egnyte Greg Neustaetter | Vice President, Products | Egnyte Ken Getz | Executive Director | Tufts CSSSD Nate McBride | Senior VP of IT | Xilio Rebecca Carazza | Executive Director | Nimbus Therapeutics |
DESCRIPTION: | Watch our speakers and Egnyte’s Life Sciences Leaders as they respond to audience questions, trends in the industry and future innovation. |
MEET YOUR SPEAKERS
Kevin Soohoo
Kevin Soohoo
Director of AEC Practice
Egnyte
COPY BLOCK
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
MEET YOUR EGNYTE SPEAKERS
MEET YOUR EGNYTE SPEAKERS
Greg Neustaetter
Greg Neustaetter
Vice President, Products
Egnyte
Catherine Hall
Catherine Hall
Head of GXP Quality Assurance
Egnyte
Abhay Kini
Abhay Kini
Director, Life Sciences
Egnyte
MEET YOUR SPEAKERS
Name
Title
Company
Name
Title
Company
COPY BLOCK
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
OUR CUSTOMERS
OUR CUSTOMERS
COMPANY AWARDS
COPY BLOCK
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
COPY BLOCK
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
ADDITIONAL RESOURCES
Unify, Protect, and Control Project Documents
A guide to improving visibility and productivity throughout a project's lifecycle.
Unify, Protect, and Control Project Documents
A guide to improving visibility and productivity throughout a project's lifecycle.
Unify, Protect, and Control Project Documents
A guide to improving visibility and productivity throughout a project's lifecycle.
MEET YOUR GUEST SPEAKERS
MEET YOUR GUEST SPEAKERS
Ken Getz
Ken Getz
Executive Director
Tufts Center for the Study of Drug Development
Dr. Rebecca Carazza
Dr. Rebecca Carazza
Executive Director
Head of Information Systems
Nimbus Therapeutics
Mike Lynch
Mike Lynch
Senior Specialist
Halloran
Karen Travers
Karen Travers
Principal
Halloran
Jacob Oppenheim
Jacob Oppenheim
Entrepreneur in Residence
Digitalis Ventures
Nate McBride
Nate McBride
Senior Vice President
Information Technology
Xilio
Jon Weiss
Jon Weiss
Partner and Chief Innovator
Basis Digital Biotech
Murtaza Cherawala
Murtaza Cherawala
Senior Director
Data Management and Artificial Intelligence
Alnylam Pharmaceuticals